Physiology and pharmacology of glucagon-like peptide-1 receptor

Physiology and pharmacology of glucagon-like peptide-1 receptor

Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight the importance of glucagon-like peptide-1 (GLP-1) r...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2024-01-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
glp-1
glucagon-like receptor-1 agonists
diabetes mellitus
incretins
Online Access:https://www.pharmpharm.ru/jour/article/view/1386
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items